STOCK TITAN

Solventum (NYSE: SOLV) CEO logs 105,963 RSU grant and tax share disposal

Filing Impact
(Very High)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Solventum Corp Chief Executive Officer Bryan C. Hanson reported multiple equity transactions. On March 5, 2026, he acquired 105,963 Restricted Stock Units (RSUs), each representing a contingent right to one share of Class A common stock.

On March 6, 2026, he exercised RSUs covering 31,907 RSUs, receiving 31,907 shares of common stock, and then disposed of 10,395 shares of common stock at $69.41 per share to cover tax withholding. After these transactions, he directly held 123,910 shares of common stock and 105,963 RSUs. The new RSU grant vests in three equal annual tranches, subject to continued service.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Hanson Bryan C

(Last) (First) (Middle)
2510 CONWAY AVE.
3M CENTER BLDG. 275-6W

(Street)
MAPLEWOOD MN 55144

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Solventum Corp [ SOLV ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Executive Officer
3. Date of Earliest Transaction (Month/Day/Year)
03/05/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 03/06/2026 M 31,907 A $0 134,305 D
Common Stock 03/06/2026 F 10,395 D $69.41 123,910 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (1) 03/05/2026 A 105,963 (2) (2) Common Stock 105,963 $0 105,963 D
Restricted Stock Units (1) 03/06/2026 M 31,907 (2) (2) Common Stock 31,907 $0 63,816 D
Explanation of Responses:
1. Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Class A Common Stock upon settlement.
2. The RSUs shall fully vest in three tranches, with one-third vesting on each of the first, second and third anniversaries of the grant date, subject to continued service through the vesting date.
Remarks:
/s/Megan Bombick, attorney-in-fact for Bryan C. Hanson 03/09/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What equity awards did Solventum (SOLV) CEO Bryan Hanson receive?

Bryan Hanson received a grant of 105,963 Restricted Stock Units (RSUs) on March 5, 2026. Each RSU represents a contingent right to receive one share of Solventum Class A common stock upon settlement, subject to future vesting conditions.

How do Bryan Hanson’s new RSUs at Solventum (SOLV) vest?

The 105,963 RSUs granted to Bryan Hanson vest in three equal tranches. One-third vests on each of the first, second, and third anniversaries of the grant date, provided he continues in service through each vesting date.

What RSU exercises did Solventum (SOLV) CEO report on March 6, 2026?

On March 6, 2026, Bryan Hanson exercised 31,907 RSUs, converting them into 31,907 shares of Solventum common stock at a stated price of $0.00 per share, reflecting a derivative exercise rather than an open-market purchase.

Why did Solventum (SOLV) CEO dispose of 10,395 shares on March 6, 2026?

Bryan Hanson disposed of 10,395 shares of Solventum common stock at $69.41 per share on March 6, 2026. The filing labels this as a tax-withholding disposition to satisfy exercise price or tax liability, not as an open-market sale for investment purposes.

What is Bryan Hanson’s Solventum (SOLV) share ownership after these transactions?

After the March 6, 2026 transactions, Bryan Hanson directly held 123,910 shares of Solventum common stock. He also directly held 105,963 RSUs, which represent additional contingent rights to shares subject to future vesting and settlement.

How many acquire vs. dispose transactions did Solventum (SOLV) CEO report?

The summary shows three acquisition-type events and one disposition. Acquisitions include the RSU grant and RSU exercise-related entries, while the single disposition reflects shares delivered to cover tax or exercise obligations rather than a traditional market sale.
Solventum Corporation

NYSE:SOLV

View SOLV Stock Overview

SOLV Rankings

SOLV Latest News

SOLV Latest SEC Filings

SOLV Stock Data

11.73B
147.21M
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
ST. PAUL